These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36739905)

  • 21. Rapid Quantitation of Four Nitrosamine Impurities in Angiotensin Receptor Blocker Drug Substances.
    Zhang J; Selaya SD; Shakleya D; Mohammad A; Faustino PJ
    J Pharm Sci; 2023 May; 112(5):1246-1254. PubMed ID: 36509171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitrosamines crisis in pharmaceuticals - Insights on toxicological implications, root causes and risk assessment: A systematic review.
    Vikram HPR; Kumar TP; Kumar G; Beeraka NM; Deka R; Suhail SM; Jat S; Bannimath N; Padmanabhan G; Chandan RS; Kumar P; Gurupadayya B
    J Pharm Anal; 2024 May; 14(5):100919. PubMed ID: 38799236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tolerability of risk: A commentary on the nitrosamine contamination issue.
    Elder DP; Johnson GE; Snodin DJ
    J Pharm Sci; 2021 Jun; 110(6):2311-2328. PubMed ID: 33705731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling the Impact of Excipients Selection on Nitrosamine Formation towards Risk Mitigation.
    Berardi A; Jaspers M; Dickhoff BHJ
    Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meeting Report: N-Nitrosamine Impurity Control Strategies in the Pharmaceutical and Biotechnology Industries.
    Roberts SW; Lennard A; Mohan G; Bernstein J; Cauchon NS; Cole S; Curristin N; Huynh-Ba K; Kolz CN; Murti C; Tang K
    AAPS J; 2021 Jul; 23(4):94. PubMed ID: 34258657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitrosated Active Pharmaceutical Ingredients - Lessons Learned?
    Holzgrabe U
    J Pharm Sci; 2023 May; 112(5):1210-1215. PubMed ID: 36720391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Full Evaporation Static Headspace Gas Chromatography Method with Nitrogen Phosphorous Detection for Ultrasensitive Analysis of Semi-volatile Nitrosamines in Pharmaceutical Products.
    Zheng J; Kirkpatrick CL; Lee D; Han X; Martinez AI; Gallagher K; Evans RK; Mudur SV; Liang X; Drake J; Buhler LA; Mowery MD
    AAPS J; 2022 Jan; 24(1):23. PubMed ID: 34993666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of N-Nitrosamine Formation in Drug Products: A Model Study.
    Nanda KK; Tignor S; Clancy J; Marota MJ; Allain LR; D'Addio SM
    J Pharm Sci; 2021 Dec; 110(12):3773-3775. PubMed ID: 34400183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trace Aldehydes in Solid Oral Dosage Forms as Catalysts for Nitrosating Secondary Amines.
    Harmon P
    J Pharm Sci; 2023 May; 112(5):1216-1219. PubMed ID: 36336102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating Nitrosamines from Elastomers in Pharmaceutical Primary Packaging.
    Boltres B
    PDA J Pharm Sci Technol; 2022; 76(2):136-150. PubMed ID: 34282037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a sensitive LC-APCI-MS/MS method for simultaneous determination of eleven nitrosamines in valsartan and irbesartan with a simple extraction approach.
    Mavis ME; Goksu Gursu G; Ular Cagatay N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Feb; 1216():123593. PubMed ID: 36669257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Landscape of Potential Small and Drug Substance Related Nitrosamines in Pharmaceuticals.
    Schlingemann J; Burns MJ; Ponting DJ; Martins Avila C; Romero NE; Jaywant MA; Smith GF; Ashworth IW; Simon S; Saal C; Wilk A
    J Pharm Sci; 2023 May; 112(5):1287-1304. PubMed ID: 36402198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitrocellulose blister material as a source of N-nitrosamine contamination of pharmaceutical drug products.
    Golob N; Grahek R; Ross M; Roškar R
    Int J Pharm; 2022 Apr; 618():121687. PubMed ID: 35314277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Method for trace determination of N-nitrosamines impurities in metronidazole benzoate using high-performance liquid chromatography coupled with atmospheric-pressure chemical ionization tandem mass spectrometry.
    Yin M; Hu Y; Fan H; Wang Q; Wang M; Wang W; Shi C
    J Sep Sci; 2023 Mar; 46(5):e2200225. PubMed ID: 36562102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The contamination of valsartan and other sartans, Part 2: Untargeted screening reveals contamination with amides additionally to known nitrosamine impurities.
    Scherf-Clavel O; Kinzig M; Besa A; Schreiber A; Bidmon C; Abdel-Tawab M; Wohlfart J; Sörgel F; Holzgrabe U
    J Pharm Biomed Anal; 2019 Aug; 172():278-284. PubMed ID: 31078064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II receptor blockers (ARBs) and manufacturing contamination: A retrospective National Register Study into suspected associated adverse drug reactions.
    Salim H; Jones AM
    Br J Clin Pharmacol; 2022 Nov; 88(11):4812-4827. PubMed ID: 35585835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of an optimized total N-nitrosamine (TONO) assay to pools: placing N-nitrosodimethylamine (NDMA) determinations into perspective.
    Kulshrestha P; McKinstry KC; Fernandez BO; Feelisch M; Mitch WA
    Environ Sci Technol; 2010 May; 44(9):3369-75. PubMed ID: 20355696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical and Science-Based Strategy for Establishing Acceptable Intakes for Drug Product
    Dobo KL; Kenyon MO; Dirat O; Engel M; Fleetwood A; Martin M; Mattano S; Musso A; McWilliams JC; Papanikolaou A; Parris P; Whritenour J; Yu S; Kalgutkar AS
    Chem Res Toxicol; 2022 Mar; 35(3):475-489. PubMed ID: 35212515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation and optimization of a HS-SPME-assisted GC-MS/MS method for monitoring nitrosamine impurities in diverse pharmaceuticals.
    Chang SH; Ho HY; Chang CC; Zang CZ; Hsu YH; Lin MC; Tseng SH; Wang DY
    J Pharm Biomed Anal; 2022 Nov; 221():115003. PubMed ID: 36095885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analytical lifecycle management for comprehensive and universal nitrosamine analysis in various pharmaceutical formulations by supercritical fluid chromatography.
    Schmidtsdorff S; Neumann J; Schmidt AH; Parr MK
    J Pharm Biomed Anal; 2021 Apr; 197():113960. PubMed ID: 33626447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.